Lau T, Bigio B, Zelli D, McEwen BS, Nasca C
Priority Applications (10) Applications Claiming Priority (1) Publications (1) Family ID=44508594 Family Applications (2) Family Applications After (1) Country Status (8) Cited By (1) Families Citing this family (1) Citations (6) Family Cites Families (1) 2011 2011-07-27 EP EP11006163A patent/EP2551350A1/en not_active Ceased 2012 2012-07-25 WO PCT/EP2012/064575 patent/WO2013014179A1/en not_active Ceased 2012-07-25 TW TW101126708A patent/TWI595093B/en not_active IP Right Cessation 2012-07-25 EP EP12738462.6A patent/EP2737074B1/en active Active 2012-07-25 JP JP2014522074A patent/JP2014521325A/en active Pending 2012-07-25 US US13/557,922 patent/US9523106B2/en active Active 2012-07-25 KR KR1020147004878A patent/KR20140057286A/en not_active Ceased 2012-07-25 AR ARP120102701A patent/AR087317A1/en unknown 2012-07-25 CN CN201280036473.6A patent/CN103703138A/en active Pending 2017 2017-01-26 JP JP2017012180A patent/JP6169812B2/en not_active Expired - Fee Related
There are studies that show that supplementation with L-Carnitine can increase the patients tolerable amount of exercise and make the symptoms of heart failure or coronary artery disease less pronounced
It also relaxes nerve cells protecting it from getting damaged further and restores nerve function
Matye, D., Leak, J., Woolbright, B
